This Week in Virology20 Heinä 2024

TWiV 1132: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr, Daniel Griffin reviews President Biden's case of COVID, reviews recent statistics on SARS-CoV-2 infection, discusses post-acute sequelae after infection during pregnancy, the use of nirmatrelvir-ritonavir for post-exposure prophylaxis, where to find Pemgarda, effectiveness of combined nirmatrelvir-ritonavir-molnupiravir treatment, effectiveness of Ensitrelvir in reducing severe outcomes in outpatients at high risk for COVID-19, effectiveness of combined nirmatrelvir-ritonavir-molnupiravir treatment in patients hospitalized with COVID-19, CDC update of Long COVID Basics page, postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras, Long COVID risk has dropped over time but remains substantial, efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID, and the interplay between diet and the gut microbiome: implications for health and disease.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

President Biden has COVID (CNN, USA Today)
COVID-19 national trend (CDC)
COVID-19 deaths (CDC)
Post–acute sequelae of COVID after infection during pregnancy (OB & Gyn)
Oral nirmatrelvir–ritonavir as postexposure prophylaxis for Covid-19 (NEJM)
Pemgarda infusion center locator (Pemgarda)
Unable to access pemgarda, gotta call Daniel (microbeTV)
CDC Quarantine guidelines (CDC)
Early phase of SARs-CoV-2 infection (COVID.gov)
NIH COVID-19 treatment guidelines (NIH)
Infectious Disease Society guidelines for treatment and management (ID Society)
Drug interaction checker (University of Liverpool)
Combined treatment of COVID reduces molnupiravir-induced mutagenicity (J Inf Dis)
Effectiveness of ensitrelvir in reducing severe outcomes in outpatients at high risk for COVID-19 (Inf Dis Therapy)
Comparative effectiveness of combination therapy with nirmatrelvir–ritonavir and remdesivir versus monotherapy (Lancet)
Molnupiravir safety and efficacy (JMV)
Convalescent plasma recommendation for immunocompromised (ID Society)
Isolation guidance (CDC)
Managing healthcare staffing shortages (CDC)
Steroids, dexamethasone at the right time (OFID)
Anticoagulation guidelines (hematology.org)
Long COVID is defined (National Academies)
Long COVID: the ANSWERS! (longcovidtheanswers.com)
The FACTS: post COVID-19=long COVID? (WHO)
The BASICS of long COVID-19 (CDC)
Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras (NEJM)
Long Covid risk has dropped over time but remains substantial (CNN)
Efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID (Clin Micro Inf)
Diet and the gut microbiome: implications for health and disease (Nat Rev Micro)
Contribute to our Floating Doctors fundraiser
Letters read on TWiV 1132
Dr. Griffin's COVID treatment summary (pdf)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(1376)

TWiV 1340: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello debate if Senator Mitch McConnell's recent hospitalization is due to post-polio syndrome or just old age, how air quality from Main...

18 Heinä 44min

TWiV 1339: Ebola up close with Tom Ksiazek

Tom Ksiazek, a world-renowned virus expert with 40 years of experience on the front lines of some of the worst outbreaks the world has ever seen, joins TWiV to discuss his career, ebolaviruses in gene...

12 Heinä 1h 50min

TWiV 1338: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are dismayed over the military deaths due to the voluntary influenza vaccination policy, FDA's first vaccine recommendations since ...

11 Heinä 42min

TWiV 1337: The whitefly and the Red Queen

TWiV explains research that reveals an an alternative evolutionary path of antiviral signalling in a sea anemone, and how a bacterial symbiont and a plant virus enhance insect fitness by inducing phys...

5 Heinä 1h 52min

TWiV 1336: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello lament about the new ACIP charter, how administration of the HPV vaccine has eliminated cervical cancer deaths in young women, the ...

4 Heinä 23min

TWiV Special: Albert Sabin with Karen Torghele

Vincent speaks with Karen Torghele about her recently published biography of polio vaccine pioneer Albert Sabin, the first ever written. Host: Vincent Racaniello Guest: Karen Torghele Subscribe (free)...

29 Kesä 1h 10min

TWiV 1335: TldR, bacterial hot rods and nullifying norovirus

TWiV explains research showing how temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling, and that IgA antibody is necessary and sufficient to prevent norovirus infectio...

28 Kesä 1h 55min

TWiV 1334: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the global economic burden of infectious disease, restoring trust in vaccinology, the Legionnaires outbreak in Harlem, new ...

27 Kesä 31min